Gliclazide

Sold as Glycron, Diaglucide, Ziclin, Glucomed, Gliclazide unicorn, Mylan gliclazide, Glygard, Tendiap mr, Gliclazide austell, Diaglucide mr, Gliclazide unicorn mr, Ran-gliclazide mr, Diaran mr, Dynacaz mr, Diamicron mr, Gluctam mr, Diaglumed, Gliclazide ascendis, Gliclazide mr ran, Glytab, Ziclagid mr, Gliclazide mr zydus, Gliclazide mr ascend, Glycobeta, Gliclazide kiara

C₁₅H₂₁N₃O₃S323.40 g/mol

1-(3,3a,4,5,6,6a-Hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea

Drag to rotate. Structure from PubChem CID 3475.

Loading Wikipedia summary

Registration

Applicants: 16
Registrations: 33
Schedule source: Consolidated Schedules 06 July 2026

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Adcock ingram limited	Glycron, Glucomed, Gliclazide unicorn	80	310311, 320089, 320110	S3	None
Servier Laboratories South Africa (Pty) LtdCertificate held by Servier Laboratories South Africa (Pty) Ltd.	Diaglucide, Tendiap mr, Diaglucide mr, Gliclazide unicorn mr, Diamicron mr, Gluctam mr, Gliclazide unicorn	30 mg, 60 mg, 80	310588, 350178, 380223, 380224, 430957, 430958, 430959, 430960, J0190	S3	PI PIL
Abbott Laboratories S.A. (Pty) Ltd	Ziclin	Not stated	310687	S3	None
Trinity Pharma (Pty) Ltd	Mylan gliclazide	Not stated	320653	S3	None
Cipla Medpro (Pty) Ltd	Glygard	Not stated	340070	S3	None
Austell Pharmaceuticals (Pty) Ltd	Gliclazide austell	40 mg, 80 mg	380206, 380207	S3	None
Unimed Healthcare (Pty) Ltd	Ran-gliclazide mr	30	410697	S3	None
Ranbaxy Pharmaceutical (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) LtdCancelled	Diaran mr	30 mg	410698	S3	PI PIL
Pharma Dynamics (Pty) Ltd	Dynacaz mr	30 mg	420249	S3	None
Ascendis Pharma (Pty) Ltd	Diaglumed, Gliclazide ascendis	80	450173, 450174	S3	None
Ranbaxy (SA) (Pty) Ltd1 of 2 cancelled	Diaran mr, Gliclazide mr ran	60	490926.927, 490927	S3	None
Forrester Pharma (Pty) Ltd	Glytab	30 mg	491207	S3	None
Zydus Healthcare (Pty) Ltd	Ziclagid mr, Gliclazide mr zydus	30 mg, 60 mg	530551, 530552, 530553.551, 530554.552	S3	None
Ascend Laboratories (Pty) Ltd	Gliclazide mr ascend	30, 60	590004, 590005	S3	None
Gulf Drug Company (Pty) Ltd	Glycobeta	Not stated	A380560	S3	None
Kiara Health (Pty) Ltd	Gliclazide kiara	80	Z0197	S3	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Glycron EACH TABLET CONTAINS GLICLAZIDE 80 mg	Not listed	31031131/21.2/0311	Registered	S3	None
Diaglucide EACH TABLET CONTAINS GLICLAZIDE 80,0 mg	Not listed	31058831/21.2/0588	Registered	S3	None
Ziclin EACH TABLET CONTAINS GLICLAZIDE 80,0 mg	Not listed	31068731/21.2/0687	Registered	S3	None
Glucomed EACH TABLET CONTAINS GLICLAZIDE 80,0 mg	Not listed	32008932/21.2/0089	Registered	S3	None
Gliclazide unicorn 80 EACH TABLET CONTAINS GLICLAZIDE 80,0 mg	80	32011032/21.2/0110	Registered	S3	None
Mylan gliclazide EACH TABLET CONTAINS GLICLAZIDE 80,0 mg	Not listed	32065332/21.2/0653	Registered	S3	None
Glygard EACH TABLET CONTAINS GLICLAZIDE 80,0 mg	Not listed	34007034/21.2/0070	Registered	S3	None
Tendiap mr 30 MG EACH TABLET CONTAINS GLICLAZIDE 30,0 mg	30 mg	35017835/21.2/0178	Registered	S3	None
Gliclazide 40 MG austell EACH TABLET CONTAINS GLICLAZIDE 40,0 mg	40 mg	38020638/21.2/0206	Registered	S3	None
Gliclazide 80 MG austell EACH TABLET CONTAINS GLICLAZIDE 80,0 mg	80 mg	38020738/21.2/0207	Registered	S3	None
Diaglucide mr 30 MG EACH TABLET CONTAINS GLICLAZIDE 30,0 mg	30 mg	38022338/21.2/0223	Registered	S3	None
Gliclazide unicorn mr 30 EACH TABLET CONTAINS GLICLAZIDE 30,0 mg	30	38022438/21.2/0224	Registered	S3	None
Ran-gliclazide mr 30 EACH TABLET CONTAINS GLICLAZIDE 30,0 mg	30	41069741/21.2/0697	Registered	S3	None
Diaran mr 30 EACH TABLET CONTAINS GLICLAZIDE 30,0 mg	30 mg.Modified release tablets	41069841/21.2/0698Approved 30 November 2022	Cancelled	S3	PI PIL
Dynacaz 30 MG mr EACH TABLET CONTAINS GLICLAZIDE 30,0 mg	30 mg	42024942/21.2/0249	Registered	S3	None
Diamicron mr 60 MG EACH TABLET CONTAINS GLICLAZIDE 60,0 mg	30 mg.Modified release tablet.	43095743/21.2/0957Approved 10 November 2017	Registered	S3	PI PIL
Gluctam mr 60 MG EACH TABLET CONTAINS GLICLAZIDE 60,0 mg	60 mg	43095843/21.2/0958	Registered	S3	None
Tendiap mr 60 MG EACH TABLET CONTAINS GLICLAZIDE 60,0 mg	60 mg	43095943/21.2/0959	Registered	S3	None
Diaglucide mr 60 MG EACH TABLET CONTAINS GLICLAZIDE 60,0 mg	60 mg	43096043/21.2/0960	Registered	S3	None
Diaglumed 80 EACH TABLET CONTAINS GLICLAZIDE 80,0 mg	80	45017345/21.2/0173	Registered	S3	None
Gliclazide 80 ascendis EACH TABLET CONTAINS GLICLAZIDE 80,0 mg	80	45017445/21.2/0174	Registered	S3	None
Diaran mr 60 Each Tablet contains: Gliclazide 60,0 mg	60	490926.92749/21.2/0926.927	Registered	S3	None
Gliclazide mr 60 ran Each Tablet contains: Gliclazide 60,0 mg	60	49092749/21.2/0927	Cancelled	S3	None
Glytab 30 MG EACH TABLET CONTAINS GLICLAZIDE 30,0 mg	30 mg	49120749/21.2/1207	Registered	S3	None
Ziclagid mr 30 MG EACH TABLET CONTAINS GLICLAZIDE 30,0 mg	30 mg	53055153/21.2/0551	Registered	S3	None
Ziclagid mr 60 MG EACH TABLET CONTAINS GLICLAZIDE 60,0 mg	60 mg	53055253/21.2/0552	Registered	S3	None
Gliclazide mr 30 MG zydus EACH TABLET CONTAINS GLICLAZIDE 30,0 mg	30 mg	530553.55153/21.2/0553.551	Registered	S3	None
Gliclazide mr 60 MG zydus EACH TABLET CONTAINS GLICLAZIDE 60,0 mg	60 mg	530554.55253/21.2/0554.552	Registered	S3	None
Gliclazide mr 30 ascend EACH TABLET CONTAINS: GLICLAZIDE 30,0 mg	30	59000459/21.2/0004	Registered	S3	None
Gliclazide mr 60 ascend EACH TABLET CONTAINS: GLICLAZIDE 60,0 mg	60	59000559/21.2/0005	Registered	S3	None
Glycobeta EACH TABLET CONTAINS GLICLAZIDE 80,0 mg	Not listed	A380560A38/21.2/0560	Registered	S3	None
Gliclazide unicorn 80 EACH TABLET CONTAINS GLICLAZIDE 80 mg	80	J0190J/21.2/190	Registered	S3	None
Gliclazide 80 kiara EACH TABLET CONTAINS GLICLAZIDE 80 mg	80	Z0197Z/21.2/197	Registered	S3	None

Regulatory status

Where S3 sits on the scale

S0S1S2S3S4S5S6S7S8

Needs a doctor's prescription, dispensed by a pharmacist.

Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S3, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Gliclazide

S3: Gliclazide
Consolidated Schedules 06 July 2026, line 3675

Pharmacological class: Oral hypoglycaemics. (class 21.2)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Diaran mr 30, Ranbaxy Pharmaceutical (Pty) Ltd is scheduled S3 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsDiaran mr 30, Ranbaxy Pharmaceutical (Pty) Ltd Patient information leaflet (PIL)For patients and carersDiaran mr 30, Ranbaxy Pharmaceutical (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background